Literature DB >> 25711032

[Association of matrix metalloproteinases' polymorphisms of MMP3 and MMP9 with development of genital endometriosis].

M I Iarmolinskaia, A S Molotkov, V F Bezhenar', N Iu Shved, T E Ivashchenko, V S Baranov.   

Abstract

We present a comparative analysis of the allelic polymorphism of the matrix metalloproteinase (MMP) gene family, including MMP3 (rs3025058), MMP7 (rs11568818), MMP9 (rs17576, rs2250889), MMP12 (rs2276109), and MMP13 (rs2252070), in patients with external genital endometriosis (EGE) and in a control group of healthy women proven to be free of disease by laparoscopic inspection. We found significant differences in the incidence of particular MMP3 and MMP9 alleles, which substantiate the role of matrix metalloproteinases in EGE pathogenesis. We used the Multifactor Dimensionality Reduction (MDR) analysis to show that 14 allelic combinations of the MMP containing MMP3 (rs3025058) x MMP7 (rs11568818) x MMP9 (rs17576) alleles showed a statistically significant association with an increased risk of EGE, while 10 other combinations correlated with a reduced risk of the disease. MDR analysis produced two statistically significant models for MMP allelic combinations involved in EGE progression, both with 100% penetrance and 83% and 78% accuracy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25711032

Source DB:  PubMed          Journal:  Genetika        ISSN: 0016-6758


  2 in total

1.  Correlation between matrix metalloproteinase-9 and endometriosis.

Authors:  Haiping Liu; Jianye Wang; Haiyu Wang; Ning Tang; Yunfei Li; Yan Zhang; Tianyu Hao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms.

Authors:  Weilin Zheng; Lixing Cao; Zheng Xu; Yuanyuan Ma; Xuefang Liang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-01       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.